Exactech Inc (EXAC) 27.12 $EXAC Exactech Shares Up 33.8%

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 9:04 AM

Exactech Inc (EXAC) 27.12 $EXAC

Exactech Shares Up 33.8% Since SmarTrend's Buy Recommendation (EXAC)
Comtex SmarTrend(R) - Tue Jul 05, 12:56PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 3 months, Exactech has returned 33.83% as of today's recent price of $26.78.
EXAC: 27.12 (+0.51)

Exactech Up 26.0% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Tue Jun 28, 12:35AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 3 months, Exactech has returned 26.04% as of today's recent price of $25.22.
EXAC: 27.12 (+0.51)

Exactech Up 32.7% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Mon Jun 20, 1:03PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 3 months, Exactech has returned 32.68% as of today's recent price of $26.55.
EXAC: 27.12 (+0.51)

Exactech Expands Competency in 3-D Printing with Purchase of Arcam Q10plus Systems
BusinessWire - Thu Jun 16, 8:00AM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this week to expand its in-house manufacturing capabilities. This investment will advance Exactech's long-term commitment to additive manufacturing technology, also known as 3-D printing.
EXAC: 27.12 (+0.51)

Exactech (EXAC) Scales a 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:58AM CDT
Share price of Exactech Inc (EXAC) reached a new 52-week high of $25.86 on Jun 14.
IRMD: 22.13 (+1.20), MASI: 52.33 (+0.34), EXAC: 27.12 (+0.51), CRY: 12.23 (+0.25)

Exactech Has Returned 26.6% Since SmarTrend Recommendation (EXAC)
Comtex SmarTrend(R) - Fri Jun 10, 1:24PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 26.59% as of today's recent price of $25.33.
EXAC: 27.12 (+0.51)

DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 6:02AM CDT
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $64.59 on Jun 9.
IRMD: 22.13 (+1.20), MASI: 52.33 (+0.34), EXAC: 27.12 (+0.51), XRAY: 63.39 (+0.89)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 3:37AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations.
IRMD: 22.13 (+1.20), MASI: 52.33 (+0.34), TROV: 5.11 (+0.30), EXAC: 27.12 (+0.51)

Exactech and University of Florida Expand Partnership, Promote Health Education with Naming of "Exactech Arena" at the Stephen C. O'Connell Center
BusinessWire - Thu Jun 09, 3:59PM CDT
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the University of Florida (UF) through naming of Exactech Arena at the newly remodeled Stephen C. O'Connell Center, a sports and entertainment complex on the university's campus.
EXAC: 27.12 (+0.51)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:39AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations in the urine of patients with non-small cell lung cancer (NSCLC).
IRMD: 22.13 (+1.20), MASI: 52.33 (+0.34), TROV: 5.11 (+0.30), EXAC: 27.12 (+0.51)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 39.65 (+0.57), MASI: 52.33 (+0.34), EXAC: 27.12 (+0.51), CRY: 12.23 (+0.25)

Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 52.33 (+0.34), INGN: 51.91 (-0.49), EXAC: 27.12 (+0.51), CRY: 12.23 (+0.25)

Shares of EXAC Up 21.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 26, 1:34PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 21.24% as of today's recent price of $24.26.
EXAC: 27.12 (+0.51)

Cynosure (CYNO) Up on FDA Approval for New 1064nm LDS
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:44AM CDT
Cynosure Inc. (CYNO) recently announced the receipt of FDA approval for marketing a new Laser Delivery System (LDS) for PicoSure.
IRMD: 22.13 (+1.20), MASI: 52.33 (+0.34), CYNO: 51.63 (+0.47), EXAC: 27.12 (+0.51)

22.3% Return Seen to Date on SmarTrend Exactech Call (EXAC)
Comtex SmarTrend(R) - Thu May 19, 1:28AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 22.29% as of today's recent price of $24.47.
EXAC: 27.12 (+0.51)

TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 5.11 (+0.30), TECH: 115.17 (unch), EXAC: 27.12 (+0.51), NVRO: 78.26 (+0.34)

Exactech Inc. (Nasdaq: EXAC) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Mon May 02, 9:00AM CDT
What:
EXAC: 27.12 (+0.51), NDAQ: 65.88 (+0.96)

Exactech Celebrates 20-Year Nasdaq Listing Anniversary
BusinessWire - Mon May 02, 8:00AM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today that in honor of the company's 20th anniversary of its Nasdaq listing, Exactech founders Bill Petty, MD, Betty Petty and Gary Miller, PhD, will ring the Nasdaq Closing Bell on Tuesday, May 3. The ceremony will take place from 3:45 - 4:00 p.m. ET at Nasdaq MarketSite in Times Square, New York.
EXAC: 27.12 (+0.51)

DexCom (DXCM) Q1 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:46AM CDT
Shares of DexCom Inc. (DXCM) fell 3.6% to close at $65.96 on Apr 28, following a disappointing first-quarter 2016 earnings release.
ANTM: 132.15 (+2.71), DXCM: 78.87 (+0.66), INGN: 51.91 (-0.49), EXAC: 27.12 (+0.51)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ardelyx Securities Fraud Suit: Key Investor Moves

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Boliden's Q3 2026 Results: What's on the Horizon?

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Steel Dynamics Gears Up for Q3 2026 Earnings Update

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

CME Group Unveils First Baseball Futures Market

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Morphe’s Auction Hits High Notes with Fine Jewelry

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

Strategic Move: Chimney Collective Teams with Four Winds

A Partnership Fueled by Legacy and Growth In the world of brick, mortar, and flue, a big play just unfolded. Chimney Collective, flexing its investment muscle, has hitched its wagon to Four Winds Chimney, a company that's carved out quite a niche in New York's chimney scene. We're not talking about a corporate takeover here; this is about putting money where growth and...

Helio Genomics Shakes Up Liver Cancer Detection Strategy

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

DIFF Eyewear Opens First Flagship Store in Charleston

DIFF Eyewear: From Clicks to Bricks in Charleston Here's a tale of a brand shaking things up, jumping from the digital stratosphere right into solid ground. DIFF Eyewear has officially planted its flag in Charleston, SC, marking a bold transition from being an exclusively online player to real-world retail. October 10th rang in their first brick-and-mortar store on...

Bill Evans Enhances Gateway's Wealth Management Expertise

Welcome Aboard, Bill Evans Some days the financial world throws a gem your way, something worth more than a rat-race racehorse in a shattered stock rally. Meet Bill Evans, a seasoned professional stepping into the vibrant arena of Gateway Financial Partners. He’s put in 29 years around the investment block, and now he’s parking himself in Glastonbury, Connecticut, set...

Hexaware Teams with Anthropic for Game-Changing AI Move

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...